Paul Singer - Elliott Investment Management
Holding/activity history for CorMedix Inc. (CRMD)
← All CRMD superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 0.14 | $5.60–17.43 · VW $11.54i | SEC | |
| 2025 Q1 | 2,444,561 | 0.14 | Reduce 14.84% | 0.04 | $6.09–13.09 · VW $9.17i | $15,058,496 | SEC |
| 2024 Q4 | 2,870,632 | 0.26 | Add 85.14% | 0.12 | $7.79–13.85 · VW $10.10i | $23,252,119 | SEC |
| 2024 Q3 | 1,550,523 | 0.12 | $8.08 | $12,528,226 | SEC | ||
| 2024 Q2 | 1,550,523 | 39.89 | $4,330.00 | $6,713,765,000 | SEC | ||
| 2024 Q1 | 1,550,523 | 0.05 | $4.24 | $6,574,218 | SEC | ||
| 2023 Q4 | 1,550,523 | 0.07 | $3.76 | $5,829,966 | SEC | ||
| 2023 Q3 | 1,550,523 | 0.08 | $3.70 | $5,736,935 | SEC | ||
| 2023 Q2 | 1,550,523 | 0.08 | $3.97 | $6,147,824 | SEC | ||
| 2023 Q1 | 1,550,523 | 0.06 | $4.14 | $6,419,165 | SEC | ||
| 2022 Q4 | 1,550,523 | 0.08 | $4.22 | $6,543,207 | SEC | ||
| 2022 Q3 | 1,550,523 | 0.06 | $2.83 | $4,388,000 | SEC | ||
| 2022 Q2 | 1,550,523 | 0.13 | $4.02 | $6,233,000 | SEC | ||
| 2022 Q1 | 1,550,523 | 0.15 | $5.48 | $8,497,000 | SEC | ||
| 2021 Q4 | 1,550,523 | 0.11 | $4.55 | $7,055,000 | SEC | ||
| 2021 Q3 | 1,550,523 | 0.08 | $4.65 | $7,210,000 | SEC | ||
| 2021 Q2 | 1,550,523 | 0.13 | $6.86 | $10,637,000 | SEC | ||
| 2021 Q1 | 1,550,523 | 0.22 | Reduce 11.82% | 0.03 | $6.41–18.80 · VW $11.16i | $15,490,000 | SEC |
| 2020 Q4 | 1,758,374 | 0.23 | $7.43 | $13,065,000 | SEC | ||
| 2020 Q3 | 1,758,374 | 0.25 | Add 110.99% | 0.13 | $3.86–6.95 · VW $5.09i | $10,603,000 | SEC |
| 2020 Q2 | 833,374 | 0.14 | $6.30 | $5,250,000 | SEC | ||
| 2020 Q1 | 833,374 | 0.07 | $3.59 | $2,992,000 | SEC |
Price snapshot:
Current price$8.32
52-week low$6.13
52-week high$14.96